Zhenyu Lin

1.7k total citations
82 papers, 1.2k citations indexed

About

Zhenyu Lin is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Zhenyu Lin has authored 82 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 23 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Zhenyu Lin's work include Colorectal Cancer Surgical Treatments (15 papers), Colorectal and Anal Carcinomas (14 papers) and Gastric Cancer Management and Outcomes (14 papers). Zhenyu Lin is often cited by papers focused on Colorectal Cancer Surgical Treatments (15 papers), Colorectal and Anal Carcinomas (14 papers) and Gastric Cancer Management and Outcomes (14 papers). Zhenyu Lin collaborates with scholars based in China, United States and Singapore. Zhenyu Lin's co-authors include Tao� Zhang, Dandan Yu, Hong Mei, Lei Zhao, Jian Wang, Gang Wu, Dejun Zhang, Brendan C. Stack, Ling Gao and Shuhua Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Zhenyu Lin

77 papers receiving 1.2k citations

Peers

Zhenyu Lin
Aibin Liang China
Yaqi Duan China
Fen Zhao China
Dakai Yang China
Hanh Khuu United States
Martin Dietrich United States
Virginie Ory United States
Yongxian Hu China
Alexander Markov Russia
Aibin Liang China
Zhenyu Lin
Citations per year, relative to Zhenyu Lin Zhenyu Lin (= 1×) peers Aibin Liang

Countries citing papers authored by Zhenyu Lin

Since Specialization
Citations

This map shows the geographic impact of Zhenyu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Lin more than expected).

Fields of papers citing papers by Zhenyu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Lin. The network helps show where Zhenyu Lin may publish in the future.

Co-authorship network of co-authors of Zhenyu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyu Lin. A scholar is included among the top collaborators of Zhenyu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyu Lin. Zhenyu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chunmiao, et al.. (2025). Sex chromosomes/hormones and the tumor microenvironment of non-reproductive cancers. Frontiers in Immunology. 16. 1642956–1642956.
2.
Liu, Xiaofeng, Liang Lin, Zhenyu Lin, et al.. (2025). Red blood cell distribution width is a short-term mortality predictor in middle-aged and older adults with hip fracture. BMC Musculoskeletal Disorders. 26(1). 261–261. 2 indexed citations
3.
Zhang, Jinjia, Haiying Chen, Zhenyu Lin, et al.. (2024). Dynamic changes in the gut microbiota during three consecutive trimesters of pregnancy and their correlation with abnormal glucose and lipid metabolism. European journal of medical research. 29(1). 117–117. 5 indexed citations
4.
Song, Zhongxiao, Li Chen, Qiang Dang, et al.. (2024). 717MO SHR-A1921 in platinum-resistant ovarian cancer (PROC): data from a first-in-human (FIH) phase I study. Annals of Oncology. 35. S549–S549. 2 indexed citations
5.
Yu, Dandan, Qilin Fan, Linli Shi, et al.. (2024). Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer. Cancer Medicine. 13(15). e70037–e70037. 4 indexed citations
6.
Lin, Zhenyu, Peng Zhang, Kaixiong Tao, & Tao� Zhang. (2024). Short-course radiotherapy (SCRT) followed by fruquintinib plus adebrelimab and CAPOX in the total neoadjuvant therapy of locally advanced rectal cancer (LARC): A multicenter, single-arm, open-label, phase II study.. Journal of Clinical Oncology. 42(16_suppl). TPS3643–TPS3643. 1 indexed citations
7.
8.
Xu, Guojie, Lei Zhao, Qingling Hua, et al.. (2023). CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway. Cell Death and Disease. 14(2). 167–167. 13 indexed citations
9.
Huang, Xiaopeng, Jinshan Zhang, Yongqiang Zheng, et al.. (2023). Alcoholic drink produced by pea is a risk factor for incident knee surgery in patients with knee osteoarthritis. Frontiers in Nutrition. 10. 1264338–1264338. 2 indexed citations
10.
11.
Lin, Zhenyu, et al.. (2023). Efficacy and safety of radiation therapy combined with anti-angiogenic agentsand immunotherapy for MSS/pMMR metastatic colorectal cancer: A real-world study.. Journal of Clinical Oncology. 41(16_suppl). e15559–e15559. 1 indexed citations
12.
Hua, Qingling, Biying Zhang, Guojie Xu, et al.. (2021). CEMIP, a novel adaptor protein of OGT, promotes colorectal cancer metastasis through glutamine metabolic reprogramming via reciprocal regulation of β-catenin. Oncogene. 40(46). 6443–6455. 41 indexed citations
13.
Wang, Haihong, Zhenyu Lin, Guiling Li, et al.. (2020). Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma. BMC Cancer. 20(1). 188–188. 9 indexed citations
14.
Wang, Jian, Zhenyu Li, Hong Mei, et al.. (2019). Antitumor effects of a covalent cyclin-dependent kinase 7 inhibitor in colorectal cancer. Anti-Cancer Drugs. 30(5). 466–474. 9 indexed citations
15.
Zhao, Lei, Dejun Zhang, Qiong Shen, et al.. (2018). KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway. Oncogene. 38(7). 935–949. 38 indexed citations
16.
Wang, Jian, Zhenyu Li, Hong Mei, et al.. (2018). Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis. Scientific Reports. 8(1). 998–998. 40 indexed citations
17.
18.
Shao, Qiang, et al.. (2014). BET Protein Inhibitor JQ1 Attenuates Myc-Amplified MCC Tumor Growth In Vivo. Cancer Research. 74(23). 7090–7102. 71 indexed citations
19.
Mei, Hong, Ye Wang, Zhenyu Lin, & Qiangsong Tong. (2013). The mTOR Signaling Pathway in Pediatric Neuroblastoma. Pediatric Hematology and Oncology. 30(7). 605–615. 24 indexed citations
20.
Lin, Zhenyu, Lijian Shao, Michael L. Morgan, et al.. (2013). Chronic mTOR activation promotes cell survival in Merkel cell carcinoma. Cancer Letters. 344(2). 272–281. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aibin Liang Breakdown of academic impact, for papers by Yaqi Duan Breakdown of academic impact, for papers by Fen Zhao Breakdown of academic impact, for papers by Dakai Yang Breakdown of academic impact, for papers by Hanh Khuu Breakdown of academic impact, for papers by Martin Dietrich Breakdown of academic impact, for papers by Virginie Ory Breakdown of academic impact, for papers by Yongxian Hu Breakdown of academic impact, for papers by Alexander Markov
Rankless by CCL
2026